• About
    • About The Event
    • FAQ
  • Agenda
    • Get Involved
    • Programs
    • Search Agenda
    • Downloads
    • In-Person Breakouts
    • Short Courses
    • Plenary Sessions
    • Speaker Biographies
    • Training Seminar
    • Attendees
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors & Floorplan
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
    • Best of Show Awards
  • Media
    • Media Partners
    • Media Gallery
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
    • Press
Discovery on Target 2025
sponsorship-exhibit-banner
Demographics Sponsors Opportunities Exhibits Lead Gen FAQ

Sponsors

 

Premier Sponsor

x-chem_Pharmaceuticals

Corporate Sponsors

      Clarivate Curia     OmniAb  SpiroChem  STEMCELL-Technologies  Wuxi-Apptec  Wuxi_Biologics


Corporate Support Sponsors

Aptamer_Group_Horizontal Ardigen_new Aurigene_Pharmaceutical_Services_NEW  Biointron_newbiosensing-instrument-logoBPS Bioscience NEW        Enamine  FidaBio_New  GENOVAC    Medicilon  Promega  PTM-BiolabsSaiSyngene_tagline  TargetMol   



Outlook YouTube LinkedIn Twitter
#BostonDOT
Stay up to Date on our Program
Plan your week image
Stay up to Date on our Program
Conference at a Glance
download-brochure
View Event Testimonial Highlights
Submit a Poster
View All Sponsors

Conference Programs

September 22

Covalent Chemistries & Induced Proximity Strategies for Targeting Kinases Emerging Immune Modulation Strategies 3D Models & NAMs in Drug Development Synthetic Biology for Drug Discovery & Development

September 23-24

Degraders & Molecular Glues – Part 1 Emerging Drug Targets: Identification & Validation Small Molecules for Cancer Targets Antibodies Against Membrane Protein Targets RNA & DNA Targeting Small Molecule Drugs AI/ML-Enabled Drug Discovery - Part 1 Targeting MASH & Obesity NEW TS8: Know Your GPCR Molecule: Four Most Common Causes of Drug Candidate Failure

September 24-25

Degraders & Molecular Glues – Part 2 Lead Generation Strategies Emerging Cancer Targets for Multispecifics, ADCs, and Biologics GPCR-Based Drug Discovery Targeting Transcription Factors & Regulators AI/ML-Enabled Drug Discovery - Part 2 TS7: Drug Exposure at the Target: The Role of ADME and Pharmacokinetics
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers

Request Information

Privacy Policy